Pfizer Claims Study Proves COVID-19 Vaccine Safe for Kids

360
SHARE

Pfizer did not publish the small sample study yet. 12-and-older participants received the same dose as adults. And Pfizer has on-going testing of different doses in younger children.

Besides the dosage amount, doctors are anxious to see evidence the shots are boosting up the test kids’ immune systems. And it has been suggested higher levels of virus-fighting antibodies are present in younger children after vaccination.

Pfizer also revealed children are having similar side effects to the shots as young adults. The side effects include pain, fever, chills, and fatigue. And they are typically more pronounced with the second dose. 

Researchers will follow the children who participated in the study for 2-years.

Pfizer CEO Albert Bourla issued a statement saying, “We share the urgency to expand the use of our vaccine.”  He added, “the hope of starting to vaccinate this age group before the start of the next school year” in the United States is the company’s goal.

In addition to Pfizer, Moderna is seeking to lower the age limit for its vaccine. The public should expect results of the studies this summer. The Moderna vaccine study tested 12- to 17-year-olds in the U.S.